Amaero Publishes June 2025 Quarterly Activities Report
Amaero Ltd (OTCQB: AMROF) has released its June 2025 quarterly activities report, highlighting significant operational and financial developments. The company reported revenue of A$1,489,000 for the quarter, comprising A$1,006,000 from powder sales and A$483,000 from PM-HIP manufacturing.
Key highlights include signing a five-year exclusive supply agreement with Velo3D expected to generate approximately A$35 million in revenue, successful commissioning of their second EIGA Premium atomizer in Tennessee, and completion of the first draw of A$5.4 million from their A$35 million EXIM Bank equipment financing. The company ended the quarter with a cash balance of A$19.2 million and tangible assets of A$50.7 million.
Amaero updated its guidance, now expecting to achieve positive EBITDA in FY2027, and confirmed having visibility to approximately 80% of planned revenue for Q1 and Q2 of FY2026.
Amaero Ltd (OTCQB: AMROF) ha pubblicato il rapporto trimestrale delle attività di giugno 2025, evidenziando importanti sviluppi operativi e finanziari. La società ha registrato un fatturato di 1.489.000 A$ per il trimestre, di cui 1.006.000 A$ derivanti dalla vendita di polveri e 483.000 A$ dalla produzione PM-HIP.
I punti salienti includono la firma di un accordo esclusivo di fornitura quinquennale con Velo3D, che dovrebbe generare circa 35 milioni di A$ di ricavi, l’avviamento con successo del secondo atomizzatore EIGA Premium in Tennessee e il completamento del primo prelievo di 5,4 milioni di A$ dal finanziamento per attrezzature da 35 milioni di A$ con EXIM Bank. La società ha chiuso il trimestre con un saldo di cassa di 19,2 milioni di A$ e attività tangibili per 50,7 milioni di A$.
Amaero ha aggiornato le sue previsioni, prevedendo ora di raggiungere un EBITDA positivo nell’esercizio 2027, confermando inoltre una visibilità su circa il 80% dei ricavi pianificati per il primo e secondo trimestre dell’esercizio 2026.
Amaero Ltd (OTCQB: AMROF) ha publicado su informe trimestral de actividades de junio de 2025, destacando importantes avances operativos y financieros. La compañía reportó un ingreso de 1.489.000 A$ en el trimestre, compuesto por 1.006.000 A$ provenientes de ventas de polvo y 483.000 A$ de fabricación PM-HIP.
Los aspectos clave incluyen la firma de un acuerdo exclusivo de suministro por cinco años con Velo3D, que se espera genere aproximadamente 35 millones de A$ en ingresos, la exitosa puesta en marcha de su segundo atomizador EIGA Premium en Tennessee y la finalización del primer desembolso de 5,4 millones de A$ de su financiamiento para equipos de 35 millones de A$ con EXIM Bank. La compañía cerró el trimestre con un saldo en efectivo de 19,2 millones de A$ y activos tangibles por 50,7 millones de A$.
Amaero actualizó sus previsiones, esperando ahora lograr un EBITDA positivo en el año fiscal 2027, y confirmó tener visibilidad sobre aproximadamente el 80% de los ingresos planificados para el primer y segundo trimestre del año fiscal 2026.
Amaero Ltd (OTCQB: AMROF)� 2025� 6� 분기 활동 보고서를 발표하며 중요� 운영 � 재무 성과� 강조했습니다. 회사� 해당 분기� 1,489,000 호주 달러� 수익� 보고했으�, � � 1,006,000 호주 달러� 분말 판매에서, 483,000 호주 달러� PM-HIP 제조에서 발생했습니다.
주요 내용으로� � 3,500� 호주 달러� 매출� 예상하는 Velo3D왶� 5� 독점 공급 계약 체결, 테네시에� � 번째 EIGA 프리미엄 아토마이저� 성공적인 가�, 그리� 3,500� 호주 달러 EXIM 은� 장비 금융에서 � 번째 인출� 540� 호주 달러 완료가 포함됩니�. 회사� 분기 말에 1,920� 호주 달러� 현금 잔고왶 5,070� 호주 달러� 유형 자산� 보유하고 있습니다.
Amaero� 가이던스를 업데이트하여 2027 회계연도� 긍정적인 EBITDA 달성� 예상하며, 2026 회계연도 1분기왶 2분기 계획� 매출� � 80%� 대� 가시성� 확보했다� 확인했습니다.
Amaero Ltd (OTCQB : AMROF) a publié son rapport d’activités trimestriel de juin 2025, mettant en avant des développements opérationnels et financiers importants. La société a déclaré un chiffre d’affaires de 1 489 000 A$ pour le trimestre, dont 1 006 000 A$ provenant des ventes de poudre et 483 000 A$ de la fabrication PM-HIP.
Les points clés incluent la signature d’un contrat d’approvisionnement exclusif de cinq ans avec Velo3D, qui devrait générer environ 35 millions A$ de revenus, la mise en service réussie de leur deuxième atomiseur EIGA Premium au Tennessee, et la réalisation du premier tirage de 5,4 millions A$ sur leur financement d’équipement de 35 millions A$ auprès de la banque EXIM. La société a terminé le trimestre avec un solde de trésorerie de 19,2 millions A$ et des actifs tangibles de 50,7 millions A$.
Amaero a mis à jour ses prévisions, s’attendant désormais à atteindre un EBITDA positif pour l’exercice 2027, et a confirmé avoir une visibilité sur environ 80 % des revenus prévus pour les premier et deuxième trimestres de l’exercice 2026.
Amaero Ltd (OTCQB: AMROF) hat seinen Quartalsbericht für Juni 2025 veröffentlicht und dabei bedeutende operative und finanzielle Entwicklungen hervorgehoben. Das Unternehmen meldete einen Umsatz von 1.489.000 A$ für das Quartal, davon 1.006.000 A$ aus Pulververkäufen und 483.000 A$ aus der PM-HIP-Produktion.
Zu den wichtigsten Highlights zählen der Abschluss eines fünfjährigen exklusiven Liefervertrags mit Velo3D, der voraussichtlich rund 35 Millionen A$ Umsatz generieren wird, die erfolgreiche Inbetriebnahme ihres zweiten EIGA Premium Zerstäubers in Tennessee sowie die Auszahlung der ersten Tranche von 5,4 Millionen A$ aus ihrer 35 Millionen A$ EXIM Bank Equipment-Finanzierung. Das Unternehmen beendete das Quartal mit einem Barguthaben von 19,2 Millionen A$ und materiellen Vermögenswerten von 50,7 Millionen A$.
Amaero aktualisierte seine Prognose und erwartet nun, im Geschäftsjahr 2027 ein positives EBITDA zu erreichen, wobei es für das erste und zweite Quartal des Geschäftsjahres 2026 eine Sichtbarkeit von etwa 80 % der geplanten Umsätze äپ.
- None.
- Delayed achievement of EBITDA breakeven from FY2026 to FY2027
- Extended Continuing Resolution for U.S. budget caused delays in revenue and new contracts
- Slower advancement of hypersonic programs through research and development phases
MCDONALD, Tenn., July 22, 2025 (GLOBE NEWSWIRE) -- Amaero Ltd (ASX:3DA) (OTCQB: AMROF) (“Amaero� or the “Company�), a leading U.S. domestic producer of high-value C103, refractory alloy, and titanium powders for additive and advanced manufacturing of components utilized by the defense, space, and aviation industries, is pleased to provide an overview of its operations to accompany the Appendix 4C for the quarterly period ending 30 June 2025 (�Quarter�, �Reporting Period�).
Highlights:
- Financial Performance
- Amaero reported revenue for the June Quarter of A
$1,489,000. Revenue included approximately A$1,006,000 from powder sales and A$483,000 from Powder Metallurgy Hot Isostatic Pressing ("PM-HIP") manufacturing. - The Company ended the June Quarter with a cash balance of A
$19.2 million . - Excluding cash, the Company ended the June Quarter with tangible assets, including prepayments for inventory and equipment, of A
$50.7 million . Note, balance sheet valuations are subject to year-end adjustments.
- Amaero reported revenue for the June Quarter of A
- Change in Company Name
- Following the Company’s 2025 extraordinary general meeting on 1 April 2025, shareholders resolved to change the Company name to Amaero Ltd from Amaero International Limited. On 8 April 2025, the change of Company name on the ASX to Amaero Ltd took effect.
- Long-Term Supply Agreement with Velo3D
- During the Quarter, Amaero signed a five-year, exclusive supply agreement with Velo3D, Inc. (OTC:VLDX) (�Velo3D�), a leading U.S. based, metal additive manufacturing technology company for mission-critical parts in the defense, space, and aviation industries.
- Based on demand estimates from Velo3D, revenue from C103 and titanium alloy powder sales over the five-year agreement are expected to equal approximately A
$35 million . Actual revenues may change and are subject to Velo3D’s production demand.
- Updated Financial Guidance
- During the Reporting Period, Amaero provided an update on previous financial guidance and expectations. The Company confirmed it now expects to achieve positive EBITDA in FY2027.
- Additionally, Amaero also reaffirmed that the planned capital investments for the 3-year period ending FY2026 was unchanged at an estimated A
$72 million and that following the A$35 million Export-Import Bank (�EXIM�) equipment financing and the recent A$22 million Placement, it is fully funded.
- Reaffirming Prior Financial Guidance
- During the Quarter, Amaero reaffirmed its prior guidance that revenue growth was expected to accelerate in the June Quarter and that revenue was expected to significantly scale in FY2026.
- Furthermore, Amaero confirmed that with contracted sales from long-term agreements and from received purchase orders, the Company has visibility to approximately
80% of its planned revenue for Q1 and Q2 of FY2026. - An updated Fairmont Consulting study released during the Reporting Period estimated demand for C103 powder at approximately 93 tonnes in FY2030 versus an earlier estimate on 8 February 2024 of approximately 105 tonnes in FY2028.
- Commissions 2nd Atomizer on Schedule
- Amaero completed commissioning of the 2nd advanced Electrode Induction Melting Inert Gas Atomizer (�EIGA Premium�) on schedule at its flagship Tennessee manufacturing facility.
- Amaero’s advanced atomizer technology is the 2nd custom designed EIGA Premium to be commissioned in the U.S. and the 3rd to be commissioned in the world.
- The Company announced a purchase order for 27 tonnes of titanium spherical powder to be shipped in 1H FY 2026.
- Key Leadership Hire
- During the Quarter, Brett Paduch was appointed Chief Financial Officer (�CFO�), effective 14 July 2025. Mr. Paduch has strong experience in FP&A, strategic planning, capital markets and M&A transactions.
- EXIM Bank Equipment Financing
- During the Quarter, the Company completed its 1st draw on the A
$35 million EXIM Bank equipment financing and received A$5.4 million of net proceeds. - The Company expects to receive approximately A
$25.2 million of additional net loan proceeds during FY2026.
- During the Quarter, the Company completed its 1st draw on the A
Hank J. Holland, Amaero Chairman and CEO, commented, “We are pleased to report a milestone quarter that positions Amaero for transformational growth as we move into FY2026. The commissioning of our second advanced atomizer in Tennessee, on schedule, underscores our commitment to building a secure, sovereign, scalable, and traceable supply chain for high-value refractory and titanium alloy powders. This expansion enhances our production capabilities and supports growing customer demand across the defense, space, aviation and medical industries.
The execution of our exclusive long-term supply agreement with Velo3D during the quarter is indicative of our strategic approach to partnerships. The partnership validates our leadership in refractory and titanium alloy powder manufacturing and reflects the trust placed in our technology, product quality, and supply chain reliability. The agreement is expected to generate up to A
We are equally encouraged by our financial position, following the recent capital raise and equipment financing with EXIM Bank, which ensures we are fully funded for our current growth phase. We remain on track with our updated guidance, including achieving positive EBITDA in FY2027 and accelerating revenue in the near term. Notably, we now have visibility to approximately
With a focus on long-term growth initiatives, the Company has prudently managed its operating expenses and its balance sheet. Since May 2022, the Company completed six capital raises that totalled A
With our strengthened leadership team, ongoing customer engagements, and strategic infrastructure investments, Amaero is exceptionally well positioned to capitalise on the increasing demand for additive and advanced manufacturing solutions and support the re-industrialisation of the United States.�
Financial Performance
Amaero reported revenue for the Quarter of A
Amaero ended the Quarter with a cash balance of A
Change in Company Name
As part of the Company’s extraordinary general meeting held on 1 April 2025, a resolution was passed by shareholders to change the name of the Company from Amaero International Limited to Amaero Ltd.
The change of the Company name process was completed, and the Australian Securities and Investment Commissions (�ASIC�) recorded the change of Company name effective 1 April 2025.
The effective date for the change of Company name on the ASX took effect from the commencement of trading on Tuesday 8 April. The Company’s ASX Ticker Code �3DA� remains unchanged.
Long-Term Supply Agreement with Velo3D
On 29 April 2025, Amaero announced it had signed a five-year, exclusive supply agreement with Velo3D, a leading U.S. based, metal additive manufacturing technology company for mission-critical parts in the defense, space, and aviation industries.
Based on demand estimates from Velo3D, revenue from C103 and titanium alloy powder sales over the five-year agreement are expected to equal approximately A
Amaero will be an exclusive supplier to Velo3D for Niobium C103 and other refractory alloy powders, including Molybdenum, Tantalum, Tungsten, and Zirconium alloys. Amaero will be preferred supplier to Velo3D for titanium alloy powders.
Velo3D will develop proprietary print parameters exclusively for Amaero’s C103 and refractory alloy powders on all Velo3D Sapphire family of printers. Velo3D will develop proprietary print parameters for Amaero’s titanium alloy powder and exclusively provide print parameters for Amaero’s titanium powders with new machine sales. The print parameters will be provided with 3D printing machine licensing at no additional cost to customers.
Velo3D will exclusively use Amaero’s C103, refractory alloy powders for all parts production, including its Rapid Production Solutions (�RPS�) initiative. Amaero will be a preferred supplier for titanium alloy powders for all parts production. Velo3D will dedicate a Sapphire machine to production with C103 powder and will dedicate a minimum of one large format Sapphire XC machine to production with titanium alloy powder. Velo3D will exclusively offer Amaero’s C103, refractory and titanium alloy powders for sale to its 3D printing machine customers.
The exclusive supply agreement underscores Amaero’s strategic initiatives to support the re-shoring of advanced manufacturing and integrated supply chains to the United States (�U.S.�).
Updated Financial Guidance
On 28 May 2025, Amaero provided an update on previous financial guidance and expectations. Key highlights included:
- On 14 August 2024, the Company estimated that it would achieve EBITDA breakeven in FY2026. The Company now expects to achieve positive EBITDA in FY2027.
- On 14 August 2024, the Company estimated that the planned capital investments for the 3-year period of FY2024-FY2026 to equal approximately A
$72 million . The Company reaffirmed that the planned capital investments for the 3-year period ending FY2026 is unchanged at an estimated A$72 million . - On 11 February 2025, the Company stated that it was fully funded following the A
$22 million Placement. The Company reaffirmed that following the A$35 million EXIM equipment financing and the A$22 million Placement, it is fully funded. - On 24 April 2025, the Company stated that it was positioned to transition to commercialisation in FY2026, that revenue growth was expected to accelerate in the June Quarter and that revenue was expected to significantly scale in FY2026. The Company reaffirmed that revenue growth is expected to accelerate in the current quarter and that revenue is expected to significantly scale in FY2026.
- The extended Continuing Resolution (�CR�) for the FY2025 congressional United States budget and the Department of Defense programs paused “new starts� and “re-starts� contributed to a delay in revenue and new contracts. Additionally, various hypersonic programs have advanced more slowly through research, development, testing, and evaluation (�RDT&E�).
Reaffirming Prior Financial Guidance
The Company gave prior guidance on 24 April 2025 and 28 May 2025 that revenue growth was expected to accelerate in the June Quarter and that revenue was expected to significantly scale in FY2026. On 23 June 2025, Amaero reaffirmed its guidance and confirmed that with contracted sales from long-term agreements and from received purchase orders, the Company has visibility to approximately
Furthermore, the A
Commissions 2nd Atomizer on Schedule
On 23 June 2025, Amaero announced that it has completed commissioning of the 2nd advanced EIGA Premium on schedule at its flagship Tennessee manufacturing facility. Amaero’s advanced atomizer technology is the 2nd custom designed EIGA Premium to be commissioned in the U.S. and the 3rd to be commissioned in the world.
The 3rd EIGA Premium atomizer that was ordered in December 2024 is on schedule to be delivered in March 2026 and to be commissioned in June 2026.
Key Leadership Hire
On 30 June 2025, Amaero confirmed the appointment of Brett Paduch as CFO, effective 14 July 2025. Mr. Paduch has strong experience in FP&A, strategic planning, capital markets and M&A transactions.
Mr Paduch previously served as CFO of a private equity owned business with US
EXIM Bank Equipment Financing
During the quarter, the Company completed its 1st draw on the A
The Company expects to receive additional net loan proceeds of approximately A
Related Party Payments
Pursuant to ASX Listing Rule 4.7C.3 and as disclosed in Item 6.1 of the attached Appendix 4C, during the Quarter A
Events Subsequent to Balance Date
On 7 July 2025, the Company confirmed that it had entered a technical development collaboration with U.S.-based Auburn University’s National Center for Additive Manufacturing Excellence (�NCAME�). Additionally, recent printing and testing of Amaero’s C103 and Ti64 (or Ti-6AI-4V) powder by NCAME has demonstrated that the powders conform with industry accepted standards and based on Auburn’s testing and certification, Amaero has satisfied Velo3D’s qualification condition.
This announcement has been authorised for release by the Board of Directors.
For further information, please contact:
Amaero Ltd Hank J. Holland Chairman and CEO [email protected] |
Media & Investor Enquiries in Australia Jane Morgan Director [email protected] |
Media & Investor Enquiries in United States Shannon Devine MZ Group [email protected] |
About Amaero
Amaero Ltd (ASX:3DA and OTC:AMROF) is an ASX-listed and OTC-listed company with manufacturing and corporate headquarters located in Tennessee, U.S. Amaero is a leading U.S. domestic producer of high-value refractory and titanium alloy powders for additive and advanced manufacturing of components utilised by the defense, space, aviation and medical industries. The technical and manufacturing team brings decades of experience and know-how with pioneering work in gas atomization of refractory and titanium alloys. The Company has commissioned advanced gas atomization technology with an industry leading yield of AM powder. The Company is also a leader in PM-HIP (Powder Metallurgy Hot Isostatic Pressing) manufacturing of large, near-net-shape powder parts with forged-equivalent material properties and microstructure for a variety of alloys. PM-HIP manufacturing is helping alleviate the strained domestic supply chain for large scale castings and forgings.
Appendix 4C
Quarterly cash flow report for entities
subject to Listing Rule 4.7B
Name of entity | ||
Amaero Ltd formerly known as Amaero International Limited | ||
ABN | Quarter ended (“current quarter�) | |
82 633 541 634 | 30 June 2025 |
Consolidated statement of cash flows | Current quarter $�000 | Year to date (12 months) $�000 | ||||
1. | Cash flows from operating activities | 1,041 | 2,580 | |||
1.1 | Receipts from customers | |||||
1.2 | Payments for | (108 | ) | (300 | ) | |
(a)research and development | ||||||
(b)product manufacturing and operating costs | (2,185 | ) | (5,302 | ) | ||
(c)advertising and marketing | (150 | ) | (369 | ) | ||
(d)leased assets | (374 | ) | (1,511 | ) | ||
(e)staff costs | (2,678 | ) | (8,970 | ) | ||
(f)administration and corporate costs | (2,785 | ) | (9,070 | ) | ||
1.3 | Dividends received (see note3) | - | - | |||
1.4 | Interest received | 171 | 649 | |||
1.5 | Interest and other costs of finance paid | - | - | |||
1.6 | Income taxes paid | (2 | ) | (5 | ) | |
1.7 | Government grants and tax incentives | 320 | 1,328 | |||
1.8 | Other (Lease Bond refund and Net GST) | 108 | 603 | |||
1.9 | Net cash from / (used in) operating activities | (6,642 | ) | (20,367 | ) | |
2. | Cash flows from investing activities | - | - | |||
2.1 | Payments to acquire or for: | |||||
(a) entities | ||||||
(g)businesses | - | - | ||||
(h)property, plant and equipment | (9,073 | ) | (23,186 | ) | ||
(i)investments | - | - | ||||
(j)intellectual property | - | - | ||||
(k)other non-current assets | - | - | ||||
2.2 | Proceeds from disposal of: | - | - | |||
(a)entities | ||||||
(l)businesses | - | - | ||||
(m)property, plant and equipment | - | - | ||||
(n)investments | - | - | ||||
(o)intellectual property | - | - | ||||
(p)other non-current assets | - | - | ||||
2.3 | Cash flows from loans to other entities | - | - | |||
2.4 | Dividends received (see note3) | - | - | |||
2.5 | Other (provide details if material) | - | - | |||
2.6 | Net cash from / (used in) investing activities | (9,073 | ) | (23,186 | ) | |
3. | Cash flows from financing activities | 1,500 | 46,683 | |||
3.1 | Proceeds from issues of equity securities (excluding convertible debt securities) | |||||
3.2 | Proceeds from issue of convertible debt securities | - | - | |||
3.3 | Proceeds from exercise of options | 188 | 665 | |||
3.4 | Transaction costs related to issues of equity securities or convertible debt securities | - | (2,335 | ) | ||
3.5 | Proceeds from borrowings | 5,424 | 5,424 | |||
3.6 | Repayment of borrowings | - | - | |||
3.7 | Transaction costs related to loans and borrowings | - | - | |||
3.8 | Dividends paid | - | - | |||
3.9 | Other (Lease Deposit) | - | - | |||
3.10 | Net cash from / (used in) financing activities | 7,112 | 50,437 | |||
4. | Net increase / (decrease) in cash and cash equivalents for the period | 28,898 | 11,988 | |||
4.1 | Cash and cash equivalents at beginning of period | |||||
4.2 | Net cash from / (used in) operating activities (item1.9 above) | (6,642 | ) | (20,367 | ) | |
4.3 | Net cash from / (used in) investing activities (item2.6 above) | (9,073 | ) | (23,186 | ) | |
4.4 | Net cash from / (used in) financing activities (item3.10 above) | 7,112 | 50,437 | |||
4.5 | Effect of movement in exchange rates on cash held | (1,076 | ) | 347 | ||
4.6 | Cash and cash equivalents at end of period | 19,219 | 19,219 |
5. | Reconciliation of cash and cash equivalents at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts | Current quarter $�000 | Previous quarter $�000 |
5.1 | Bank balances | 19,219 | 28,898 |
5.2 | Call deposits | - | - |
5.3 | Bank overdrafts | - | - |
5.4 | Other (provide details) | - | - |
5.5 | Cash and cash equivalents at end of quarter (should equal item4.6 above) | 19,219 | 28,898 |
6. | Payments to related parties of the entity and their associates | Current quarter $A'000 |
6.1 | Aggregate amount of payments to related parties and their associates included in item1 | 756 |
6.2 | Aggregate amount of payments to related parties and their associates included in item2 | - |
Note: if any amounts are shown in items 6.1 or 6.2, your quarterly activity report must include a description of, and an explanation for, such payments. |
7. | Financing facilities Note: the term “facility� includes all forms of financing arrangements available to the entity. Add notes as necessary for an understanding of the sources of finance available to the entity. | Total facility amount at quarter end $�000 | Amount drawn at quarter end $�000 |
7.1 | Loan facilities | - | - |
7.2 | Credit standby arrangements | - | - |
7.3 | Other (please specify) * | 34,826 | 6,034 |
7.4 | Total financing facilities | - | - |
7.5 | Unused financing facilities available at quarter end * | 28,792 | |
7.6 | Include in the box below a description of each facility above, including the lender, interest rate, maturity date and whether it is secured or unsecured. If any additional financing facilities have been entered into or are proposed to be entered into after quarter end, include a note providing details of those facilities as well. | ||
As announced on 26 February 2025: Credit Agreement Signed for US A fixed interest rate of The loan commitment reflects an advance of During the quarter, the Company drew down A *Amount Subject to conditions |
8. | Estimated cash available for future operating activities | $�000 | |
8.1 | Net cash from / (used in) operating activities (item1.9) | (6,642 | ) |
8.2 | Cash and cash equivalents at quarter end (item4.6) | 19,219 | |
8.3 | Unused finance facilities available at quarter end (item7.5) | 28,792 | |
8.4 | Total available funding (item8.2 + item8.3) | 48,011 | |
8.5 | Estimated quarters of funding available (item8.4 divided by item8.1) | 7.23 | |
Note: if the entity has reported positive net operating cash flows in item1.9, answer item8.5 as “N/A�. Otherwise, a figure for the estimated quarters of funding available must be included in item8.5. | |||
8.6 | If item8.5 is less than 2quarters, please provide answers to the following questions: | ||
8.6.1Does the entity expect that it will continue to have the current level of net operating cash flows for the time being and, if not, why not? | |||
Answer: N/A | |||
8.6.2Has the entity taken any steps, or does it propose to take any steps, to raise further cash to fund its operations and, if so, what are those steps and how likely does it believe that they will be successful? | |||
Answer: N/A | |||
8.6.3Does the entity expect to be able to continue its operations and to meet its business objectives and, if so, on what basis? | |||
Answer: N/A | |||
Note: where item8.5 is less than 2quarters, all of questions 8.6.1, 8.6.2 and 8.6.3 above must be answered. |
Compliance statement
1This statement has been prepared in accordance with accounting standards and policies which comply with Listing Rule19.11A.
2This statement gives a true and fair view of the matters disclosed.
Date:.................. 21 July 2025....................................
Authorised by: ...............The Board of Directors..........................
(Name of body or officer authorising release � see note4)
Notes
1.This quarterly cash flow report and the accompanying activity report provide a basis for informing the market about the entity’s activities for the past quarter, how they have been financed and the effect this has had on its cash position. An entity that wishes to disclose additional information over and above the minimum required under the Listing Rules is encouraged to do so.
2.If this quarterly cash flow report has been prepared in accordance with Australian Accounting Standards, the definitions in, and provisions of, AASB 107: Statement of Cash Flows apply to this report. If this quarterly cash flow report has been prepared in accordance with other accounting standards agreed by ASX pursuant to Listing Rule19.11A, the corresponding equivalent standard applies to this report.
3.Dividends received may be classified either as cash flows from operating activities or cash flows from investing activities, depending on the accounting policy of the entity.
4.If this report has been authorised for release to the market by your board of directors, you can insert here: “By the board�. If it has been authorised for release to the market by a committee of your board of directors, you can insert here: “By the [name of board committee � eg Audit and Risk Committee]�. If it has been authorised for release to the market by a disclosure committee, you can insert here: “By the Disclosure Committee�.
5.If this report has been authorised for release to the market by your board of directors and you wish to hold yourself out as complying with recommendation4.2 of the ASX Corporate Governance Council’s Corporate Governance Principles and Recommendations, the board should have received a declaration from its CEO and CFO that, in their opinion, the financial records of the entity have been properly maintained, that this report complies with the appropriate accounting standards and gives a true and fair view of the cash flows of the entity, and that their opinion has been formed on the basis of a sound system of risk management and internal control which is operating effectively.
